Authors: Rawstron, AC Kennedy, B Evans, PAS Davies, FE Richards, SJ Haynes, AP Russell, NH Hale, G Morgan, GJ Jack, AS Hillmen, P

Citation: Ac. Rawstron et al., Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome andcan be used to optimize therapy, BLOOD, 98(1), 2001, pp. 29-35

Authors: Richards, SJ Rawstron, AC Hillmen, P

Citation: Sj. Richards et al., Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria, CYTOMETRY, 42(4), 2000, pp. 223-233

Authors: Hillmen, P Richards, SJ

Citation: P. Hillmen et Sj. Richards, Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria, BR J HAEM, 108(3), 2000, pp. 470-479

Authors: Richards, SJ Morgan, GJ Hillmen, P

Citation: Sj. Richards et al., Immunophenotypic analysis of B cells in PNH: insights into the generation of circulating naive and memory B cells, BLOOD, 96(10), 2000, pp. 3522-3528

Authors: Rawstron, AC Rollinson, SJ Richards, S Short, MA English, A Morgan, GJ Hale, G Hillmen, P

Citation: Ac. Rawstron et al., The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment, BR J HAEM, 107(1), 1999, pp. 148-153

Authors: Richards, SJ Morgan, GJ Hillmen, P

Citation: Sj. Richards et al., Analysis of T cells in paroxysmal nocturnal hemoglobinuria provides directevidence that thymic T-cell production declines with age, BLOOD, 94(8), 1999, pp. 2790-2799